share_log

Synaptics Analyst Ratings

Benzinga ·  Aug 4, 2023 06:42
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/04/2023 11.38% Needham → $100 Reiterates Buy → Buy
07/26/2023 5.81% Wells Fargo $75 → $95 Maintains Equal-Weight
06/06/2023 28.09% Needham → $115 Reiterates Buy → Buy
05/04/2023 -10.89% BMO Capital $135 → $80 Maintains Market Perform
05/04/2023 28.09% Craig-Hallum $150 → $115 Maintains Buy
05/04/2023 28.09% Needham $165 → $115 Maintains Buy
05/04/2023 11.38% Rosenblatt $160 → $100 Maintains Buy
05/04/2023 -16.46% Wells Fargo $105 → $75 Maintains Equal-Weight
05/04/2023 44.8% Mizuho $155 → $130 Maintains Buy
05/04/2023 11.38% Keybanc $140 → $100 Maintains Overweight
04/25/2023 55.94% Susquehanna $145 → $140 Maintains Positive
04/24/2023 117.2% Oppenheimer $185 → $195 Maintains Outperform
04/24/2023 55.94% Keybanc $160 → $140 Maintains Overweight
04/11/2023 16.95% Wells Fargo $125 → $105 Maintains Equal-Weight
02/03/2023 61.51% Susquehanna $115 → $145 Maintains Positive
02/03/2023 67.08% Craig-Hallum $120 → $150 Maintains Buy
02/03/2023 67.08% Cowen & Co. $100 → $150 Maintains Outperform
02/03/2023 50.37% BMO Capital $90 → $135 Maintains Market Perform
02/03/2023 Oppenheimer Downgrades Outperform → Perform
02/03/2023 78.21% Keybanc $115 → $160 Maintains Overweight
01/27/2023 28.09% Wells Fargo $90 → $115 Maintains Equal-Weight
11/04/2022 0.25% Wells Fargo $100 → $90 Maintains Equal-Weight
11/04/2022 0.25% BMO Capital $110 → $90 Maintains Market Perform
11/04/2022 78.21% Mizuho $205 → $160 Maintains Buy
11/04/2022 44.8% Needham $140 → $130 Maintains Buy
11/04/2022 28.09% Keybanc $130 → $115 Maintains Overweight
10/31/2022 22.52% Cowen & Co. $210 → $110 Maintains Outperform
10/11/2022 11.38% Wells Fargo $155 → $100 Maintains Equal-Weight
09/12/2022 106.06% Needham $220 → $185 Maintains Buy
08/08/2022 111.63% Oppenheimer $230 → $190 Maintains Outperform
08/05/2022 128.34% Keybanc $215 → $205 Maintains Overweight
08/05/2022 128.34% Mizuho $225 → $205 Maintains Buy
07/12/2022 139.47% Keybanc $250 → $215 Maintains Overweight
07/11/2022 39.23% Wells Fargo $175 → $125 Maintains Equal-Weight
05/06/2022 150.61% Mizuho $250 → $225 Maintains Buy
05/06/2022 256.43% Rosenblatt $345 → $320 Maintains Buy
05/06/2022 195.17% Needham $340 → $265 Maintains Buy
04/18/2022 178.46% Mizuho $290 → $250 Maintains Buy
04/12/2022 178.46% Keybanc $310 → $250 Maintains Overweight
04/07/2022 106.06% Wells Fargo → $185 Initiates Coverage On → Equal-Weight
02/04/2022 278.7% Needham $320 → $340 Maintains Buy
12/31/2021 284.27% Rosenblatt $290 → $345 Maintains Buy
12/15/2021 256.43% Needham $300 → $320 Maintains Buy
12/14/2021 256.43% Susquehanna $275 → $320 Maintains Positive
11/30/2021 245.29% Keybanc $270 → $310 Maintains Overweight
11/08/2021 217.44% Oppenheimer $165 → $285 Maintains Outperform
11/05/2021 Summit Insights Group Upgrades Hold → Buy
11/05/2021 234.15% Needham $220 → $300 Maintains Buy
11/05/2021 178.46% Mizuho $195 → $250 Maintains Buy
11/05/2021 200.74% Keybanc $230 → $270 Maintains Overweight
10/05/2021 156.18% Keybanc $220 → $230 Maintains Overweight
08/31/2021 122.77% Cowen & Co. $176 → $200 Maintains Outperform
08/31/2021 122.77% Rosenblatt $175 → $200 Maintains Buy
08/31/2021 145.04% Keybanc $190 → $220 Maintains Overweight
08/23/2021 117.2% Mizuho $178 → $195 Maintains Buy
08/11/2021 94.92% Arete Research → $175 Downgrades Buy → Neutral
08/06/2021 94.92% Rosenblatt $165 → $175 Maintains Buy
08/06/2021 145.04% Needham $200 → $220 Maintains Buy
08/06/2021 111.63% Keybanc $170 → $190 Maintains Overweight
07/15/2021 94.92% Mizuho $145 → $175 Maintains Buy
07/14/2021 89.35% Keybanc $160 → $170 Maintains Overweight
05/07/2021 83.78% Rosenblatt $150 → $165 Maintains Buy
05/07/2021 122.77% Needham $180 → $200 Maintains Buy
05/07/2021 106.06% Morgan Stanley $173 → $185 Maintains Overweight
05/07/2021 78.21% Keybanc $145 → $160 Maintains Overweight
04/27/2021 96.03% Cowen & Co. $130 → $176 Upgrades Market Perform → Outperform
03/29/2021 100.49% Needham $150 → $180 Maintains Buy
03/10/2021 94.92% JP Morgan $129 → $175 Upgrades Neutral → Overweight
02/24/2021 92.69% Morgan Stanley → $173 Initiates Coverage On → Overweight
02/05/2021 67.08% Rosenblatt $110 → $150 Maintains Buy
02/05/2021 67.08% Needham $130 → $150 Maintains Buy
02/05/2021 55.94% Oppenheimer → $140 Upgrades Perform → Outperform
02/05/2021 Craig-Hallum Upgrades Hold → Buy
02/05/2021 61.51% Keybanc $120 → $145 Maintains Overweight
01/21/2021 22.52% JP Morgan $73 → $110 Upgrades Underweight → Neutral
01/06/2021 33.66% KeyBanc $100 → $120 Maintains Overweight
11/30/2020 -5.32% Cowen & Co. → $85 Initiates Coverage On → Market Perform
11/06/2020 44.8% Needham $120 → $130 Maintains Buy
11/06/2020 22.52% Rosenblatt $95 → $110 Maintains Buy
08/06/2020 0.25% BMO Capital $70 → $90 Maintains Market Perform
08/06/2020 5.81% Rosenblatt $86 → $95 Maintains Buy
08/06/2020 33.66% Needham $100 → $120 Maintains Buy
08/06/2020 11.38% Keybanc → $100 Upgrades Sector Weight → Overweight
07/21/2020 -4.21% Rosenblatt $73 → $86 Maintains Buy
07/21/2020 11.38% Susquehanna $68 → $100 Upgrades Neutral → Positive
07/08/2020 -18.69% Rosenblatt $66 → $73 Upgrades Neutral → Buy
06/15/2020 -26.49% Rosenblatt → $66 Initiates Coverage On → Neutral
03/31/2020 5.81% Keybanc → $95 Downgrades Overweight → Sector Weight
03/20/2020 -55.45% JP Morgan $73 → $40 Downgrades Neutral → Underweight
02/07/2020 11.38% Needham $80 → $100 Maintains Buy
02/07/2020 -10.89% Mizuho $77 → $80 Maintains Buy
02/07/2020 5.81% Keybanc $80 → $95 Maintains Overweight
02/07/2020 -18.69% JP Morgan $52 → $73 Upgrades Underweight → Neutral
01/16/2020 Mizuho Upgrades Neutral → Buy
01/03/2020 -10.89% Keybanc → $80 Upgrades Sector Weight → Overweight
12/19/2019 Summit Insights Group Upgrades Hold → Buy
12/17/2019 -49.88% Rosenblatt → $45 Downgrades Neutral → Sell
11/18/2019 -55.45% JP Morgan $32 → $40 Maintains Underperform
11/08/2019 -64.36% JP Morgan $25 → $32 Maintains Underweight
08/09/2019 -63.24% BMO Capital $29 → $33 Maintains Market Perform
08/09/2019 -55.45% Dougherty & Co. → $40 Upgrades Neutral → Buy
08/09/2019 -72.15% JP Morgan $35 → $25 Downgrades Neutral → Underweight
08/09/2019 -55.45% Dougherty & Co. → $40 Upgrades Neutral → Buy
05/10/2019 -61.02% Mizuho $39 → $35 Maintains Neutral
03/19/2019 -61.02% BMO Capital $42 → $35 Maintains Market Perform
03/18/2019 -49.88% JP Morgan $50 → $45 Maintains Neutral
03/18/2019 -56.56% Mizuho $48 → $39 Downgrades Buy → Neutral
02/08/2019 -44.31% JP Morgan $55 → $50 Downgrades Overweight → Neutral
12/07/2018 -57.67% Susquehanna → $38 Initiates Coverage On → Neutral
11/09/2018 Keybanc Downgrades Overweight → Sector Weight
08/10/2018 -38.74% JP Morgan $52 → $55 Maintains Overweight
08/10/2018 -50.99% BMO Capital $39 → $44 Maintains Market Perform

What is the target price for Synaptics (SYNA)?

The latest price target for Synaptics (NASDAQ: SYNA) was reported by Needham on August 4, 2023. The analyst firm set a price target for $100.00 expecting SYNA to rise to within 12 months (a possible 11.38% upside). 32 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Synaptics (SYNA)?

The latest analyst rating for Synaptics (NASDAQ: SYNA) was provided by Needham, and Synaptics reiterated their buy rating.

When is the next analyst rating going to be posted or updated for Synaptics (SYNA)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Synaptics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Synaptics was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.

Is the Analyst Rating Synaptics (SYNA) correct?

While ratings are subjective and will change, the latest Synaptics (SYNA) rating was a reiterated with a price target of $0.00 to $100.00. The current price Synaptics (SYNA) is trading at is $89.78, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment